@article{lemoine:hal-03830790,
TITLE = {Nouvelle AMM: le brexucabtagene autoleucel pour les leuc{\'e}mies aigu{\"e}s lymphoblastiques B de l'adulte en rechute ou r{\'e}fractaires},
AUTHOR = {Lemoine, Jean and Marchand, Tony},
URL = {https://hal.science/hal-03830790},
JOURNAL = {Bulletin du Cancer},
PUBLISHER = {John Libbey Eurotext},
VOLUME = {109},
NUMBER = {12},
PAGES = {1232-1233},
YEAR = {2022},
MONTH = Oct, DOI = {10.1016/j.bulcan.2022.09.006},
KEYWORDS = {Acute lymphoblastic leukemia ; Immunotherapy ; Brexucabtagene autoleucel ; CAR-T CD19 ; Immunoth{\'e}rapie ; Leuc{\'e}mie aigu{\"e} lymphoblastique},
PDF = {https://hal.science/hal-03830790/file/Lemoine-2022-Nouvelle%20AMM_Manuscrit_KTE-X19_BullCancer_VF_TM2.pdf},
HAL_ID = {hal-03830790},
HAL_VERSION = {v1},
}